4 Reasons Not To Buy Biotechs Yet |
| April 06, 2014 | April 2014 Bond Updates |
|
Biotech stocks dropped again, but four reasons indicate that waiting remains the best strategy. Attitudes of investors appear not to have turned negative yet and, therefore, biotech stocks are susceptible to more selling. |
| View more at: http://www.forbes.com/sites/johntobey/2014/04/05/4-reasons-not-to-buy-biotechs-yet/ |
| Related News |
|